Andrew D. Regan

744 total citations
13 papers, 557 citations indexed

About

Andrew D. Regan is a scholar working on Infectious Diseases, Animal Science and Zoology and Genetics. According to data from OpenAlex, Andrew D. Regan has authored 13 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Animal Science and Zoology and 8 papers in Genetics. Recurrent topics in Andrew D. Regan's work include Virus-based gene therapy research (8 papers), Animal Virus Infections Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Andrew D. Regan is often cited by papers focused on Virus-based gene therapy research (8 papers), Animal Virus Infections Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Andrew D. Regan collaborates with scholars based in United States, Switzerland and France. Andrew D. Regan's co-authors include Gary R. Whittaker, Beth N. Licitra, Jean K. Millet, Vera D. Rinaldi, G Duhamel, Brian S. Hamilton, Richard A. Cerione, Bo Li, Stephanie S. Dusaban and Qiyu Feng and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Andrew D. Regan

13 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew D. Regan United States 10 365 328 227 85 58 13 557
Zexu Ma United States 13 325 0.9× 162 0.5× 118 0.5× 105 1.2× 9 0.2× 19 650
J P Norcott United Kingdom 8 322 0.9× 196 0.6× 45 0.2× 141 1.7× 11 0.2× 8 562
Seong Jun Park South Korea 12 129 0.4× 139 0.4× 90 0.4× 146 1.7× 16 0.3× 40 444
Sheng‐Li Ming China 12 99 0.3× 88 0.3× 60 0.3× 137 1.6× 19 0.3× 28 433
Anna Rice United States 10 88 0.2× 94 0.3× 105 0.5× 139 1.6× 60 1.0× 15 358
Wanju Zhang China 15 227 0.6× 74 0.2× 92 0.4× 124 1.5× 43 0.7× 25 505
Glen A. Farr United States 10 143 0.4× 87 0.3× 230 1.0× 202 2.4× 3 0.1× 14 466
Nicholas Boddicker United States 11 131 0.4× 314 1.0× 307 1.4× 76 0.9× 9 0.2× 26 550
A. J. Kenyon United States 11 81 0.2× 74 0.2× 121 0.5× 64 0.8× 79 1.4× 37 333
Christopher E. Yi United States 7 329 0.9× 107 0.3× 22 0.1× 157 1.8× 21 0.4× 10 489

Countries citing papers authored by Andrew D. Regan

Since Specialization
Citations

This map shows the geographic impact of Andrew D. Regan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Regan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Regan more than expected).

Fields of papers citing papers by Andrew D. Regan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Regan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Regan. The network helps show where Andrew D. Regan may publish in the future.

Co-authorship network of co-authors of Andrew D. Regan

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Regan. A scholar is included among the top collaborators of Andrew D. Regan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Regan. Andrew D. Regan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Licitra, Beth N., Jean K. Millet, Andrew D. Regan, et al.. (2013). Mutation in Spike Protein Cleavage Site and Pathogenesis of Feline Coronavirus. Emerging infectious diseases. 19(7). 1066–1073. 146 indexed citations
2.
Regan, Andrew D., Jean K. Millet, Longping V. Tse, et al.. (2012). Characterization of a recombinant canine coronavirus with a distinct receptor-binding (S1) domain. Virology. 430(2). 90–99. 39 indexed citations
3.
Regan, Andrew D., David G. Ousterout, & Gary R. Whittaker. (2010). Feline Lectin Activity Is Critical for the Cellular Entry of Feline Infectious Peritonitis Virus. Journal of Virology. 84(15). 7917–7921. 29 indexed citations
4.
Antonyak, Marc A., Bo Li, Andrew D. Regan, et al.. (2009). Tissue Transglutaminase Is an Essential Participant in the Epidermal Growth Factor-stimulated Signaling Pathway Leading to Cancer Cell Migration and Invasion. Journal of Biological Chemistry. 284(27). 17914–17925. 69 indexed citations
5.
6.
Regan, Andrew D., et al.. (2008). Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses. Veterinary Microbiology. 132(3-4). 235–248. 48 indexed citations
7.
Regan, Andrew D. & Gary R. Whittaker. (2008). Utilization of DC-SIGN for Entry of Feline Coronaviruses into Host Cells. Journal of Virology. 82(23). 11992–11996. 43 indexed citations
8.
Madu, Ikenna G., Victor C. Chu, Hwajin Lee, et al.. (2007). Heparan Sulfate Is a Selective Attachment Factor for the Avian Coronavirus Infectious Bronchitis Virus Beaudette. Avian Diseases. 51(1). 45–51. 64 indexed citations
9.
Madu, Ikenna G., Victor C. Chu, Hwajin Lee, et al.. (2007). Heparan Sulfate is a Selective Attachment Factor for the Avian Coronavirus IBV Beaudette. Avian Diseases Digest. 2(1). e8–e8. 1 indexed citations
10.
Rahl, Peter B., Benjamin Briggs, Monica Calero, et al.. (2006). Bioinformatic and Comparative Localization of Rab Proteins Reveals Functional Insights into the Uncharacterized GTPases Ypt10p and Ypt11p. Molecular and Cellular Biology. 26(19). 7299–7317. 50 indexed citations
11.
Regan, Andrew D. & Gary R. Whittaker. (2006). Entry of Rhabdoviruses Into Animal Cells. Advances in experimental medicine and biology. 790. 167–177. 16 indexed citations
12.
Luehrman, Timothy A. & Andrew D. Regan. (1993). Genzyme Corporation: A Financing History. 1 indexed citations
13.
Hayes, Samuel L. & Andrew D. Regan. (1992). Securities Underwriting and Investment Banking Competition. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zexu Ma Breakdown of academic impact, for papers by J P Norcott Breakdown of academic impact, for papers by Seong Jun Park Breakdown of academic impact, for papers by Sheng‐Li Ming Breakdown of academic impact, for papers by Anna Rice Breakdown of academic impact, for papers by Wanju Zhang Breakdown of academic impact, for papers by Glen A. Farr Breakdown of academic impact, for papers by Nicholas Boddicker Breakdown of academic impact, for papers by A. J. Kenyon Breakdown of academic impact, for papers by Christopher E. Yi
Rankless by CCL
2026